ArticleFrontiers in medicine2026
Toward visualized pathophenotyping: a multimodal imaging-guided conceptual framework for chronic low back pain.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic low back pain (CLBP) remains a leading cause of disability, yet many current interventions are limited by operator dependence and an inability to target deep pathophysiological drivers. This Perspective proposes Visualized Pathophenotyping, a conceptual precision paradigm that integrates multimodal imaging to characterize patient-specific deep structural and perfusion abnormalities and guide targeted interventions. The framework comprises three pillars: (1) precise assessment using shear wave elastography and infrared thermography or laser Doppler flowmetry to define mechanical and ischemic phenotypes; (2) ultrasound-guided deep mechanical stimulation for accurate targeting of fascial adhesions and myofascial trigger points; and (3) phenotype-specific intelligent monitoring with virtual/augmented reality and wearable AI to sustain tissue remodeling and prevent recurrence. Emerging evidence from randomized trials and meta-analyses suggests that visualization-guided approaches yield superior short-term pain relief and functional improvement compared with blind techniques. Digital therapeutics may enhance adherence and some functional outcomes, although broader biopsychosocial effects remain to be confirmed. By shifting CLBP management from operator-dependent procedures toward objective, data-driven care, this hypothesis-generating framework may reduce recurrence, minimize opioid reliance, and improve scalability, pending validation through prospective multicenter trials of diagnostic accuracy, clinical utility, and cost-effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.